Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Southern California, Los Angeles, CA.
Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, CA.
Int J Cancer. 2018 Mar 1;142(5):1022-1032. doi: 10.1002/ijc.31084. Epub 2017 Oct 16.
This study seeks to identify risk factors associated with ovarian metastasis and to characterize a population with minimum risk of ovarian metastasis in young women with stage IB-IIB cervical cancer. This was a nation-wide multicenter retrospective study in Japan examining consecutive cases of surgically-treated women with clinical stage IB-IIB cervical cancer who had oophorectomy at radical hysterectomy (n = 5,697). Multivariable analysis was performed to identify independent risk factors for ovarian metastasis. Ovarian metastasis was seen in 70 (1.2%, 95% confidence interval 0.9-1.5) cases. In the entire cohort, adenocarcinoma, lympho-vascular space invasion, uterine corpus tumor invasion, and pelvic/para-aortic nodal metastases remained independent risk factors for ovarian metastasis (all, adjusted-p < 0.05). In a sensitivity analysis of 3,165 women aged <50 years (ovarian metastasis, 1.0%), adenocarcinoma, parametrial tumor involvement, uterine corpus tumor involvement, and pelvic/para-aortic nodal metastases remained independent risk factors for ovarian metastasis (all, adjusted-P < 0.05). In the absence of these five risk factors (representing 46.1% of women aged <50 years), the incidence of ovarian metastasis was 0.14%. With the presence of adenocarcinoma alone (representing 18.9% of women aged <50 years), the incidence of ovarian metastasis was 0.17% and was not associated with increased risk of ovarian metastasis compared to the subgroup without any risk factors (p = 0.87). In conclusion, nearly two thirds of women aged <50 years with clinical stage IB-IIB cervical cancer had no risk factor for ovarian metastasis or had adenocarcinoma alone: these subgroups had ovarian metastasis rates of around 0.1% and may be a candidate population for ovarian conservation at surgical treatment.
这项研究旨在确定与卵巢转移相关的风险因素,并描述在临床分期为 IB-IIB 的年轻宫颈癌女性中,卵巢转移风险最低的人群。这是一项在日本进行的全国性多中心回顾性研究,共纳入 5697 例接受根治性子宫切除术时行卵巢切除术的临床分期为 IB-IIB 宫颈癌女性患者。采用多变量分析确定卵巢转移的独立危险因素。70 例(1.2%,95%置信区间 0.9-1.5)发生卵巢转移。在全队列中,腺癌、淋巴血管间隙浸润、子宫体肿瘤侵犯和盆腔/主动脉旁淋巴结转移仍然是卵巢转移的独立危险因素(均为调整后 P<0.05)。在年龄<50 岁的 3165 例女性的敏感性分析中(卵巢转移 1.0%),腺癌、宫旁肿瘤累及、子宫体肿瘤累及和盆腔/主动脉旁淋巴结转移仍然是卵巢转移的独立危险因素(均为调整后 P<0.05)。如果不存在这 5 个危险因素(占年龄<50 岁女性的 46.1%),卵巢转移的发生率为 0.14%。如果仅存在腺癌(占年龄<50 岁女性的 18.9%),卵巢转移的发生率为 0.17%,与无任何危险因素的亚组相比,卵巢转移的风险无增加(P=0.87)。总之,近三分之二的年龄<50 岁的临床分期为 IB-IIB 的宫颈癌患者无卵巢转移的危险因素或仅有腺癌:这些亚组的卵巢转移率约为 0.1%,可能是手术治疗时卵巢保留的候选人群。